Human IL12b and IL23a recombiant protein

Reference: PX-P6270-100
Product nameHuman IL12b and IL23a recombiant protein
Uniprot IDQ9NPF7 & P29460
Origin speciesHomo sapiens (Human)
Expression systemEukaryotic expression
Molecular weightReduced: 20 kDa & 44 kDa; Nonreduced: 60 kDa
Protein delivered with Tag?N-Terminal His Tag
Purity estimated>85% by SDS-PAGE
Buffer0.01M PBS, pH 7.4.
Delivery conditionDry Ice
Storage condition4°C for short term (1 week), -20°C or -80°C for long term (avoid freezing/thawing cycles; addition of 20-40% glycerol improves cryoprotection)
BrandProteoGenix
Host speciesMammalian cells
Fragment Type(Arg20-Pro189) & (Ile23-Ser328)
Aliases /SynonymsInterleukin-23, IL23, IL-23, interleukin 12
ReferencePX-P6270
NoteFor research use only

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Human IL12b and IL23a recombiant protein”

Your email address will not be published. Required fields are marked *

Related products

Tildrakizumab Biosimilar – Anti-IL23A mAb – Research Grade
Biosimilar Tildrakizumab Biosimilar – Anti-IL23A mAb – Research Grade PX-TA1309 400€
Guselkumab Biosimilar – Anti-IL23A mAb – Research Grade
Biosimilar Guselkumab Biosimilar – Anti-IL23A mAb – Research Grade PX-TA1327 300€
Risankizumab Biosimilar – Anti-IL23A mAb – Research Grade
Biosimilar Risankizumab Biosimilar – Anti-IL23A mAb – Research Grade PX-TA1396 300€
Brazikumab Biosimilar – Anti-IL23A mAb – Research Grade
Biosimilar Brazikumab Biosimilar – Anti-IL23A mAb – Research Grade PX-TA1449 400€
Mirikizumab Biosimilar – Anti-IL23A mAb – Research Grade
Biosimilar Mirikizumab Biosimilar – Anti-IL23A mAb – Research Grade PX-TA1489 400€
Ustekinumab Biosimilar – Anti-Human IL-12 IL-23 mAb – Research Grade
Biosimilar Ustekinumab Biosimilar – Anti-Human IL-12 IL-23 mAb – Research Grade PX-TA1011 300€
Anti His tag mouse monoclonal antibody
Tag Antibody Anti His tag mouse monoclonal antibody PTX17851-100 180€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.